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Abstract 
Purpose: To isolate and identify chemical components of Phyllostachys prominens (Poaceae) leaf 
extracts, and measure their antioxidant activities.  
Methods: Ethanol extracts of P. prominens leaves were subjected to different chromatographic 
methods: macroporous resin column chromatography, Sephadex LH-20 column chromatography, and 
semi-preparative, reversed-phase (RP) high performance liquid chromatography (HPLC). Plant extract 
components were identified by ultraviolet spectroscopy (UV), mass spectrometry (MS), and nuclear 
magnetic resonance spectroscopy (NMR). DPPH (1,1-diphenyl-2-picrylhydrazyl) assay was used to 
measure the radical scavenging activity of the compounds .  
Results: We isolated fourteen compounds including six flavonoids, two lignans, two phenolic 
glycosides, a phenolic acid, a phenylpropanoid, a monoterpene glycoside, and amarusine from the 
leaves of Phyllostachys prominens. The DPPH assay showed that eleven compounds (compounds 1, 4, 
6, 7, 8, 9, 10, 11, 12, 13, and 14) exhibited radical scavenging activity. (The half maximal inhibitory 
concentration ranged from 33.52 to 100.58 μg/mL). The half maximal inhibitory concentration (IC50) 
values of compounds 1, 4, 6 and 7 were 33.52, 40.61, 47.10, and 35.84 μg/mL respectively, while the 
IC50 of the positive control, butylated hydroxytoluene, was 46.32 μg/mL. 
Conclusion: Fourteen compounds have been successfully all isolated from Phyllostachys prominens 
for the first time. Eleven of the compounds have radical scavenging activity. 
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Bamboo is a perennial plant of the Gramineae 
family that grows in China, Korea, Japan, and 
other parts of Southeast Asia, and represents an 
important commodity. It is used as a building 
material, handicraft component, food ingredient, 
and component of traditional medicines. Bamboo 
leaves have a long medicinal utilization history in 
China [1]. Bamboo leaf extracts have been 
reported to contain flavonoids, coumarins, 
lignans, polysaccharides, and anthraquinones[2]. 
In the past few years, reports have described the 
beneficial effects of bamboo leaf extracts on 
human health, which include antioxidant, anti-
aging, antibacterial, lipid regulating, and anti-
tumor activities [3-7]. 
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Phyllostachys prominens, which belongs to the 
tribe Bambuseae, is an important bamboo 
species that is widely distributed in the south of 
China [8]. Phyllostachys prominens is not only 
used as a building material, but also as a source 
of high quality edible bamboo shoots. However, 
huge leaves of Phyllostachys prominens are 
generally disposed of as waste; thus, how to 
utilize such large amounts of bamboo leaves is 
an urgent problem. Exploring the medical value 
of bamboo leaves could potentially uncover a 
solution to this problem. Synthetic antioxidants 
have many risks because of their carcinogenicity 
and toxicity to the liver. Therefore, the 
development and utilization of more effective 
antioxidants of natural origins is desired. 
 
However, at present, little work has been done 
on the chemical composition of leaf extracts from 
Phyllostachys prominens. Therefore, in this 
research, we isolated and identified the chemical 
components of Phyllostachys prominens leaf 
extracts, and evaluated the antioxidant activity of 




Materials and equipment 
 
Column chromatography  for fractionation of leaf 
extracts was carried out using a semi-preparative 
reversed-phase (RP) column packed with 
macroporous resin (AB-8, 10 × 80 mm), 
Sephadex LH-20 (GE Healthcare), and semi-
preparative RP high performance liquid 
chromatography (HPLC) (Shimadzu) with an 
YMC-Pack ODS-A column (250 × 10 mm, 5 μm, 
particles). UV spectra were determined using a 
Waters 2695 HPLC with a photodiode array 
detector (PAD). NMR spectra were scanned 
using a Bruker instrument operating at 300 MHz. 
Mass spectroscopy was performed on an Agilent 





Phyllostachys prominens leaves were collected 
from Hangzhou City, Zhejiang Province, China in 
September 2013. The plant identity was 
confirmed by Professor Chen Shuang-Lin from 
the Research Institute of Subtropical Forest, 
Chinese Academy of Forestry. A voucher 
specimen (No. 201310-00) has been deposited 
in the state forestry administration Key Open 
Laboratory, International Center for Bamboo and 
Rattan in Beijing, China. 
 
Extraction and isolation  of compounds from 
Phyllostachys prominens leaves 
 
Five kilograms of dried Phyllostachys prominens 
leaves were ground to a powder and extracted 
three times with 95 % ethanol at room 
temperature. The extracts were combined and 
evaporated under reduced pressure at 318 K on 
a rotary evaporator to yield a solid residue. The 
residue (451.0 g) was resuspended in water, 
followed by successive partition with ethyl 
acetate (111.0 g) and n-butanol (55.0 g). 
 
During the following fractionation steps, HPLC 
analysis of the fractions was performed. Briefly, 
1.0 ml of each fraction was filtered through a 
0.45 μm membrane filter before 10 μL was 
injected into the UPLC system for analysis. The 
mobile phase was composed of solutions A 
(MeOH) and B (Water) with a gradient elution, 
and the flow rate was 1.0 mL/min. For semi-
preparative HPLC steps, the fraction was filtered 
through a 0.45 μm membrane filter before 100 μL 
was injected into the semi-preparative UPLC 
system. The mobile phase was composed of 
solutions A (MeOH) and B (Water) and the flow 
rate of the mobile phase was 6.0 mL/min. 
 
The n-butanol phase was separated on a 
macroporous resin column through successive 
elution with a gradient of increasing ethanol (0, 
15, 30, 50, and 100 %) yielding five fractions (E1-
E5) based on HPLC analysis. Fraction E2 (8.0 g) 
was applied to a Sephadex LH-20 column 
(equilibrated with H2O) to obtain subfractions E2-
1-E2-32 based on HPLC analysis. Separation of 
E2-14 (146.5 mg) with RP semi-preparative 
HPLC (14 % MeOH in H2O) yielded compound 1 
(7.5 mg), compound 2 (20.0 mg), and compound 
3 (20.0 mg). Separation of E2-20 (100.0 mg) with 
RP semi-preparative HPLC (20 % MeOH in H2O) 
yielded compound 4 (25.0 mg) and compound 5 
(19.0 mg). Separation of E2-23 (175 mg) with RP 
semi-preparative HPLC (30 % MeOH in H2O) 
yielded compound 6 (22.0 mg), compound 7 
(17.0 mg), and compound 8 (9.5 mg).  
 
The ethyl acetate fraction was further 
fractionated on a silica gel column by eluting with 
a gradient of petroleum ether and acetone with 
increasing polarity to obtain eight fractions (F1-
F8) based on HPLC analysis. F3 was passed 
over a silica gel column and eluted with a 
gradient of petroleum ether and acetone that 
yielded ten sub-fractions (F3-1-F3-10). F3-7 (230 
mg) were subjected to semi-preparative RP 
HPLC (40 % MeOH in H2O), which yielded 
compound 9 (25.0 mg), compound 10 (24.0 mg), 
and compound 11 (41.HPLC (44 % MeOH in 
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H2O) yielded compound 12 (33.0 mg), compound 
13 (28.0 mg), and compound 14 (45.0 mg).  
 
Measurement of radical scavenging activity 
by DPPH assay  
 
These 14 compounds were evaluated for radical 
scavenging activity using a modified DPPH 
assay (Sigma, St. Louis, MO, USA) [9]. Briefly, 
each compound was dissolved in 400 μL of 
DMSO and serially diluted to 200, 100, 50, 20, 
10, and 5 µg/mL. The reaction mixtures 
consisted of 200 μL of each serial dilution and 
200 µg/mL DPPH in triplicate. After 30 min of 
incubation in the dark, the absorbance of each 
reaction was read at 517 nm. The positive control 
was butylated hydroxytoluene (BHT). The half 
maximal inhibitory concentration (IC50) values 
represent the concentration of sample at which 
50 % of the DPPH was scavenged. Data were 




Fourteen compounds were isolated from leaf 
extracts of Phyllostachys prominens, and were 
identified according to the HRMS, 1H-NMR, and 
13C-NMR analyses. Their chemical structures are 
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Figure 1: Structures of compounds (1-14) isolated from Phyllostachys prominens 
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Compound 1: White amorphous powder (7.5 
mg). 1H-NMR (DMSO-d6, 300 MHz) δ: 8.43 (1H, 
s, OH-4), 6.68 (1H, s, H-2), 6.68 (1H, s, H-6), 
6.41 (1H, s, OH-2’), 4.97 (1H, d, J = 10.5 Hz, H-
7), 2.58 (1H, m, H-8), 3.75 (1H, m, H-9a), 3.39 
(1H, m, H-9b), 4.17 (1H, s, OH-9), 3.76 (6H, s, 
OCH3-3, 5), 4.97 (1H, H-4', d, 1.5 Hz), 4.18 (1H, 
m, H-5'), 5.64, 5.63 (1H, OH-5', d, 3.5 Hz), 3.99 
(1H, H-6' a, dd, J = 10.0, 5.0 Hz), 3.90 (1H, dd, J 
= 10.0 Hz, 5.0 Hz, H-6' b). 13C-NMR (DMSO-d6, 
300 MHz) δ: 174.2 (C-1'), 148.0 (C-5, 3), 136.0 
(C-4), 129.2 (C-1), 116.9 (3'), 105.3 (C-6), 89.0 
(C-4'), 85.5 (C-7), 80.0 (C-2'), 74.1 (C-6' a), 73.7 
(C-5'), 56.7 (C-9a), 56.5 (OCH3-3, 5), 55.6 (C-8). 
HR-EI-MS m/z: 383.0972[M-H]- (calculated for 
C17H20O10, 384.0984). These data are in good 
agreement with those of amarusine A [10]. 
 
Compound 2: White amorphous powder (20.0 
mg). 1H-NMR (DMSO-d6, 300 MHz) δ: 7.83 (2H, 
d, J = 9.0 Hz, H-2'', 6''), 6.86 (2H, d, J = 9.0 Hz, 
H-3'', 5''), 4.51 (1H , dd, J = 12.0, 2.0 Hz, H-6'), 
4.25 (1H, d, J = 8.0Hz, H-1'), 3.97 (1H, dd, J = 
10.0, 3.0 Hz, H-1), 3.74 (1H, m, H-3), 3.45 (1H, 
m, H-5'), 3.42 (1H, m, H-4), 3.39 (1H, m, H-2), 
3.37 (1H, m, H-5), 3.21 (1H, m, H-3'), 3.22 (1H, 
m, H-3'), 3.04 (1H, m, H-2'). 13C-NMR (DMSO-d6, 
300 MHz) δ: 165.8 (C-7''), 162.5 (C-4''), 131.2 
(C-6'', 2''), 120.3 (C-1''), 115.8 (C-3'', 5''), 103.8 
(C-1'), 76.6 (C-3'), 74.2 (C-5'), 74.1 (C-2), 73.1 
(C-4), 72.8 (C-2'), 71.9 (C-1), 71.2 (C-3), 70.5 (C-
4'), 63.5 (C-5), 64.1 (C-6'). HR-EI-MS m/z: 
433.1433 [M-H]- (calculated for C18H26O12, 
434.1424). These data are in good agreement 
with those of xylitol 1-O-(6'-O-p-
hydroxylbenzoyl)-glucopyranoside [11]. 
 
Compound 3: White powder (20.0 mg). 1H-NMR 
(DMSO-d6, 300 MHz) δ: 7.42 (2H, d, J= 7.5 Hz, 
H-2, 6), 7.33 (2H, t, J= 7.5 Hz, H-3, 5), 7.28 (1H, 
d, J= 7.5 Hz, H-4), 4.93 (1H, d, J = 11.9 Hz, H-
7a), 4.67 (1H, d, J= 11.9 Hz, H-7b), 4.36 (d, J= 
7.7 Hz, H-1'), 3.91 (1H, dd, J= 11.9, 1.9 Hz, H-
6'), 3.70 (1H, dd, J= 11.9, 5.7 Hz, H-6'), 3.25-
3.33 (2H, m, H-2', 5'). 13C-NMR (DMSO-d6, 300 
MHz) δ: 138.0 (C-1), 128.2 (C-3, C-5), 128.0 (C-
2, C-6), 127.8 (C-4), 102.1 (C-1'), 77.7 (C-5'), 
78.1 (C-3'), 74.9 (C-2'), 71.5 (C-4'), 70.5 (C-7), 
61.7 (C-6'). HR-EI-MS m/z: 269.1109 [M-H]- 
(calculated for C13H18O6, 270.1103). These data 
are in good agreement with those of benzyl-O-β-
D-glucopyranoside [12]. 
 
Compound 4: Yellowish amorphous powder 
(25.0 mg). 1H-NMR (DMSO-d6, 300 MHz) δ: 1.99 
(2H, m, H-2), 3.93 (1H, brs, H-3), 3.55 (1H, m, H-
4), 5.09 (1H, d, J = 4.9 Hz , H-5), 1.78 (2H, m, H-
6), 7.04 (1H, d, J = 1.6 Hz, H-2' ), 6.77 (1H, d, J 
= 8.1Hz, H-5'), 6.98 (1H, dd, J = 1.6, 8.2 Hz, H-
6'), 7.43 (1H, d, J = 15.9Hz, H-7'), 6.16 (1H, d, J 
= 15.9 Hz, H-8'). 13C-NMR (DMSO-d6, 300 MHz) 
δ: 175.5 (C-7), 166.2 (C-9'), 148.7 (C-4'), 145.9 
(C-7'), 145.2 (C-3'), 126.0 (C-1'), 121.6 (C-6' ), 
116.1 (C-5'), 115.2 (C-2'), 114.8 (C-3'), 71.3 (C-
1, 3), 68.7 (C-4, 5), 37.7 (C-2), 36.8 (C-6). HR-
EI-MS m/z: 353.0934 [M-H]- (calculated for 
C16H18O9, 354.0950). These data are in good 
agreement with those of 5-O-caffeoylquinic acid 
[13]. 
 
Compound 5: White powder (19.0 mg). 1H-NMR 
(DMSO-d6, 300 MHz) δ: 5.93 (1H, d, J = 15.3 Hz, 
H-7), 5.74 (1H, s, H-4), 5.62 (1H, dd, J = 15.3 
Hz, 6.0 Hz, H-8), 4.98 (1H, brs, 6-OH), 4.40 (1H,  
m, H-9), 4.06 (1H, d, J = 7.2 Hz, H-1c), 2.52 (1H, 
d, J =16.5Hz, H-2a), 2.03 (1H, d, J = 16.5 Hz, H-
2e), 1.79 (1H, s, H-11), 1.16 (1H, d, J = 6.16 Hz, 
H-10), 0.90 (1H, s, H-13), 0.89 (1H, s, H-12), 
2.89~5.12 (glu-H). 13C-NMR (DMSO-d6, 300 
MHz) δ:198.7 (C-3), 164.4 (C-5), 131.9 (C-8), 
131.7 (C-7), 125.8 (C-4), 100.1 (C-1'), 78.1 (C-
6'), 77.6 (C-3' ), 73.4 (C-9), 72.3 (C-2'), 70.1 (C-
4'), 61.2 (C-6' ), 49.6 (C-2), 41.2 (C-1), 24.3 (C-
12), 23.3 (C-13), 22.2 (C-11), 18.9 (C-10). HR-
EI-MS m/z: 385.1945 [M-H]- (calculated for 
C19H30O8, 386.1940). These data are in good 
agreement with those of (6s,9s)-drummondol-9-
O-β-D-glucopyranoside [14]. 
 
Compound 6: Yellowish amorphous powder 
(22.0 mg). 1H-NMR (DMSO-d6, 300 MHz) δ: 6.75 
(1H, s, H-2), 6.75 (1H, s, H-6), 5.51 (1H, s, H-7), 
4.25 (1H, m, H-8), 3.61 (2H, s, H-9), 6.73 (1H, s, 
H-2'), 6.73 (1H, s, H-6'), 6.38 (1H, s, H-7'), 6.46 
(1H, s, H-8'), 4.11 (2H, s, H-9'), 4.34 (1H, s, H-
1'''), 3.08 (1H, m, H-2'''), 3.15 (1H, s, H-3'''), 3.05 
(1H, s, H-4'''), 3.04 (1H, s, H-5'''), 4.11 (2H, s, H-
6'''), 3.73 (6H, s, 3-OCH3), 3.74 (6H, s, 5-OCH3). 
13C-NMR (DMSO-d6, 300 MHz) δ: 153.1 (C-3'), 
153.1 (C-5'), 147.7 (C-3), 147.7 (C-5), 135.9 (C-
4'), 135.0 (C-4), 132.9 (C-1'), 130.6 (C-7'), 129.4 
(C-1), 128.9 (C-8'), 105.7 (C-2'), 105.7 (C-6'), 
104.1 (C-2), 104.1 (C-6), 102.5 (C-1'''), 84.5 (C-
8), 79.1 (C-7), 77.7 (C-5'''), 76.9 (C-3'''), 74.6 (C-
2'''), 70.4 (C-4'''), 61.8 (C-9'), 61.3 (C-6'''), 60.6 
(C-9), 56.4 (3, 5-OCH3). HR-EI-MSm/z: 597.2255 
[M-H]- (calculated for C28H38O14, 598.2261). 
These data are in good agreement with those of 
3,5,3',5'- tetramethoxy -4-hydroxyl-(8-O-cinnamyl 
alcohol)-7-O-glucoside [15]. 
 
Compound 7: White powder (17.0 mg).1H-NMR 
(DMSO-d6, 300 MHz) δ: 6.66 (4H, s, H-2, 6, 2', 
6'), 4.91 (1H, s, H-7'), 4.99 (1H, s, H-2''), 4.85 
(1H, s, H-7), 4.16 (1H, s, H-1''), 3.76 (12H, s, H-
OCH3), 3.89, 3.56 (2H, s, H-9), 3.48, 3.53 (1H, s, 
H-9'), 3.44, 3.46 (2H, m, H-6''), 3.11 (1H, s, H-
5''), 3.08 (1H, m, H-3''), 3.05 (1H, m, H-4''), 2.32 
(1H, s, H-8'), 2.12 (1H, s, H-8). 13C-NMR 
(DMSO-d6, 300 MHz) δ: 148.3 (C-3), 148.3 (C-
Xu et al 
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3'), 135.2 (C-4), 135.0 (C-4'), 133.5 (C-1'), 133.2 
(C-1), 104.4 (C-6), 104.4 (C-6'), 104.4 (C-2), 
104.4 (C-2'), 103.7 (C-1''), 82.6 (C-7'), 86.2 (C-7), 
77.3 (C-5''), 74.0 (C-2''), 77.2 (C-3''), 70.5 (C-4''), 
69.4 (C-2), 61.52 (C-6''), 60.36 (C-9'), 55.5 (C-
OCH3), 53.7 (C-8), 50.7 (C-8'). HR-EI-MS m/z: 
597.2213 [M-H]- (calculated for C28H38O14, 
598.2261). These data are in good agreement 




Compound 8: Yellowish syrup (9.5 mg). 1H-
NMR (DMSO-d6, 300 MHz) δ: 7.58 (1H, d, J = 
16.1, H-7'), 7.53 (2H, d, J= 8.5 H-2', 6'), 6.78 (2H, 
d, J = 8.5, H-3', 5'), 6.67 (2H, s, H-2, 6), 6.36 
(2H, s, H-8'), 4.47 (2H, d, J = 6.3, H-7), 4.35 (1H, 
s, H-1''), 4.80 (dd, J  = 6.3, 13.2), 4.21 (2H, s, H-
9), 4.10 (1H, s, H-8), 3.73 (6H, s, 3, 5-OCH3), 
3.61, 3.41 (2H, s, H-6''), 3.14 (2H, s, H-3''), 3.04 
(2H, s, H-4''), 3.03(2H, s, H-5'').13C-NMR 
(DMSO-d6, 300 MHz) δ:166.8(C-9'), 160.7 (C-4'), 
147.9 (C-3, 5), 145.1 (C-7'), 135.2 (C-4), 133.2 
(C-1') 129.7 (C-1), 116.2 (C-3', 5'), 114.3 (C-8), 
105.0 (C-2), 104.3 (C-1''), 83.6 (C-7), 77.3 (C-3''), 
72.6 (C-8), 70.4 (C-4''), 65.4 (C-9), 61.4 (C-6''), 
56.4 (3, 5-OCH3). HR-EI-MS m/z: 551.1853 [M-
H]- (calculated for C26H32O13, 552.1842). These 





Compound 9: Yellow amorphous powder (25.0 
mg). 1H-NMR (DMSO-d6, 300 MHz) δ: 12.98 (1H, 
s, 5-OH), 7.41 ( 2H, dd, J = 8.5, 2.5 Hz, H-2', 6'), 
6.88 (1H, d, J = 8.5 Hz, H-5'), 6 .76 (1H, d, J = 
2.5 Hz, H-8), 6.76 (1H, s, H-3), 6.44 (1H, d, J = 
2.5 Hz, H-6), 5.07 (1H, d, J = 6.0 Hz, H-1''), 3.15-
3.70 (4H, m, Glu). 13C-NMR (DMSO-d6, 300 
MHz) δ: 182.3 (C-4), 164.9 (C-2), 163.0 (C-7), 
161.1 (C-5), 157.3 (C-9), 150.5 (C-4'), 145.9 (C-
3'), 121.6 (C-1'), 119.5 (C-6'), 116.4 (C-5'), 113.9 
(C-2'), 105.7 (C-10), 103.5 (C-3), 100.3 (C-1''), 
99.9 (C-6), 95.1 (C-8), 77.6 (C-5''), 76.8 (C-3''), 
73.5 (C-21''), 70.5 (C-4''), 61.0 (C-6''). HR-EI-MS 
m/z: 447.1015[M-H]- (calculated for C21H20O11, 
448.1005). These data are in good agreement 
with those of luteolin-7-O-glucoside [17]. 
 
Compound 10: Yellow powder (24.0 mg). 1H-
NMR (DMSO-d6, 300 MHz) δ: 7.48 (2H, dd, J = 
8.5, 2.5 Hz, H-2', 6'), 6.88 (1H, d, J = 8.5 Hz, H-
5'), 6.76 (1H, s, H-3), 6.44 (1H, d, J = 2.5 Hz, H-
6), 3.15-3.70 (4H, m, L-arabinose). 13C-NMR 
(DMSO-d6, 300 MHz) δ: 182.4 (C-4), 164.6 (C-2), 
163.2 (C-7), 161.0 (C-5), 156.0 (C-9), 150.2 (C-
4'), 145.9 (C-3'), 121.9 (C-1'), 120.7 (C-6'), 116.6 
(C-5'), 114.1 (C-2'), 104.9 (C-10), 104.3 (C-3), 
102.6 (C-6), 99.0 (C-8), 75.2 (C-1''), 75.1 (C-3''), 
71.3 (C-5''), 69.3 (C-4''), 68.4 (C-2''). HR-EI-MS 
m/z: 417.0887 [M-H]- (calculated for C20H18O10, 
418.0899). These data are in good agreement 
with those of luteolin -8-C-α-L-arabinose [17]. 
 
Compound 11: Yellowish powder (41.0 mg). 1H-
NMR (DMSO-d6, 300 MHz) δ: 13.15 (1H, brs, 5-
OH), 7.44 (1H, dd, J = 2.5, 9.0 Hz, H-6′), 7.38 
(1H, d, J = 2.5 Hz, H-2′), 6.90 (1H, d, J = 9.0 Hz, 
H-5′), 6.64 (1H, s, H-3), 4.58 (1 H, d, J =10.0 Hz, 
H-1″). 13C-NMR (DMSO-d6, 300 MHz) δ: 181.4 
(C- 4), 163.4 (C-7), 163.4 (C-2), 160.6 (C-5), 
156.3 (C-9), 150.4 (C-4'), 146.0 (C-3'), 121.6 (C-
1'), 118.8 ( C-6'), 116.0 (C-5'), 112.9 (C-2'), 108.9 
(C-6), 102.8 (C-10), 102.4 (C-3), 93.7 (C-8), 81.4 
(C-5''), 79.0 (C-1''), 73.2 (C-2''), 70.5 (C-3''), 70.2 
(C-4''), 61.3 (C-6''). HR-EI-MS m/z: 447.1050[M-
H]- (calculated for C21H20O10, 448.1056). These 
data are in good agreement with those of 
isoorientin [18]. 
 
Compound 12: Yellow powder (33.0 mg). 1H-
NMR (DMSO-d6, 300 MHz) δ: 7.48( 2H, dd, J = 
8.5, 2.5 Hz, H-2', 6'), 7.02 (1H, s, H-3), 6.91 (1H, 
d, J = 2.5 Hz, H-6), 6.46 (1H, d, J = 2.0 Hz, H-8), 
3.89 (6H, s, 3', 5'-OCH3), 5.01 (1H, d, J = 8.0 Hz, 
H-1''). 13C-NMR (DMSO-d6, 300 MHz) δ: 182.3 
(C-4), 164.4 (C-2), 163.2 (C-7), 161.3 (C-5), 
157.1 (C-9), 148.4 (C-3', 5') 140.3 (C-4'), 120.4 
(C-1'), 105.6 (C-10), 104.7 (C-2', 6'), 104.0 (C-3), 
99.8 (C-6), 95.6 (C-8), 100.4 (C-1''), 77.5 (C-5''), 
76.7(C-3''), 73.4 (C-2''), 69.9 (C-4''), 60.6 (C-6''). 
HR-EI-MS m/z: 491.1451[M-H]- (calculated for 
C23H24O12, 492.1268). These data are in good 
agreement with those of tricin-7-O-β-D-glucoside 
[18]. 
 
Compound 13: Yellow powder (28.0 mg). 1H-
NMR (DMSO-d6, 300 MHz) δ: 7.48(2H, dd, J = 
8.5, 2.5 Hz, H-2', 6'), 7.02 (1H, s, H-3), 6.91 (1H, 
d, J = 2.5 Hz, H-6), 6.46 (1H, d, J = 2.0 Hz, H-8), 
3.89 (6H, s, 3', 5'-OCH3), 5.01 (1H, d, J = 8.0 Hz, 
H-1''). 13C-NMR (DMSO-d6, 300 MHz) δ: 177.5 
(C-4), 163.0 (C-2), 161.5 (C-7), 159.0 (C-5), 
158.8 (C-9), 148.6 (C-3', 5'), 139.9 (C-4'), 120.9 
(C-1'), 108.7 (C-10), 106.8 (C-3), 104.9 (C-6), 
104.8 (C-2', 6'), 104.6 (C-1''), 98.9 (C-8), 77.9 (C-
5''), 76.0 (C-3''), 74.0 (C-2''), 70.1 (C-4''), 61.3 (C-
6''), 56.8 (3', 5'-OCH3). HR-EI-MS m/z: 491.1451 
[M-H]- (calculated for C23H24O12, 492.1268). 
These data are in good agreement with those of 
tricin-5-O-β-D-glucoside [17]. 
 
Compound 14: Yellow powder (45.0 mg). 1H-
NMR (DMSO-d6, 300 MHz) δ: 7.82 (2H, d, J = 
6.0 Hz, H-2', 6'), 6.66 (1H, s, H-3), 6.40 (1H, s, 
H-8), 6.82 (2H, d, J = 6.0 Hz, H-3', 5'), 4.97 (2H, 
d, J = 6.0 Hz, H-1''), 4.27 (1H, d, J = 3.0 Hz, H-
1'''). 13C-NMR (DMSO-d6, 300 MHz) δ: 182.5 (C-
4), 163.5 (C-2), 156.7 (C-4'), 161.6 (C-5), 160.5 
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(C-9), 128.9 (C-2', 6'), 121.6 (C-1'), 116.6 (C-3', 
5'), 105.2 (C-10), 109.3 (C-6), 100.9 (C-1'''), 81.9 
(C-5''), 80.6 (C-3''), 76.3 (C-2''), 75.3 (C-2'''), 72.1 
(C-4'''), 71.9 (C-1''), 71.1 (C-4''), 70.6 (C-3'''), 
68.7 (C-5'''), 62.2 (C-6''), 18.0 (C-6'''). HR-EI-MS 
m/z: 577.1632 [M-H]- (calculated for C27H30O14, 
578.1635). These data are in good agreement 
with those of isovitexin-2''-xylopyranoside [18]. 
 
Compounds 1-14 were tested for antioxidant 
activity using the DPPH method. The results are 
shown in Table 1. Compounds 1, 4, 6, 7, 9, 10, 
11, 12, 13, and 14 exhibited the ability to 
scavenge radicals with IC50 of 33.52 μg/mL, 
40.61 μg/mL, 47.10 μg/mL, 35.84 μg/ml, 67.89 
μg/mL, 56.24 μg/mL, 100.58 μg/mL, 78.11 
μg/mL, 83.06 μg/mL, and 88.25 μg/mL, 
respectively. BHT was used as the positive 
control; the IC50 of BHT was 46.32 μg/mL. By 
comparison, compounds 2, 3, 5, and 8 had no 
radical scavenging capacity. 
 








4 40.61± 2.39 
5 - 
6 47.10±1.95 
7 35.84± 0.97 
8 - 
9 67.89± 2.77 
10 56.24± 2.13 
11 100.58 ± 5.84 
12 78.11± 4.13 
13 83.06± 3.25 
14 88.25± 2.28 
BHT 46.32±1.61 




In the present study, 14 compounds, including 
six flavonoids, two lignans, two phenolic 
glycosides, a phenolic acid, a phenylpropanoid, a 
monoterpene glycoside, and amarusine, were 
isolated from the leaves of Phyllostachys 
prominens. To our knowledge, these were the 
first compounds isolated from leaf extracts of 
Phyllostachys prominens that subsequently were 
shown to have anti-oxidant activities. 
 
Bamboo leaves are rich in flavonoids [3],which 
were considered to have many functions, such 
as removing active oxygen, preventing hemal 
sclerosis, improving nutrition for tissue, antiaging 
and preventing aging dementia[6]. In our study, 
we also six flavonoids exhibting antioxidant 
activity. In addition to flavonoids, we isolated two 
lignans from the bamboo leaf extracts. Lignans, 
which are a type of phytoestrogen, have a variety 
of biological activities including antioxidant 
activity [19]. In the future research on the 
chemical constituents of bamboo leaves, more 
attention should be paid on lignans. 
 
The DPPH assay results showed that, in addition 
to flavonoids, the two lignans and phenolic acid, 
which are important compounds in bamboo 
leaves, also had antioxidant activity. These 
findings suggest that the antioxidant activity of 
the bamboo leaf extracts could be attributed to 




Chemical utilization of Phyllostachys prominens 
leaves may be a way to solve the problem of 
excess quantities of bamboo leaves that are 
disposed of as waste. Importantly, bamboo 
leaves have been reported to contain 
compounds with anti-oxidant properties. To our 
knowledge, we were the first to isolate fourteen 
different (1-14) compounds from the leaves of 
Phyllostachys prominens.  Moreover, 11 
compounds (1, 4, 6, 7, 8, 9, 10, 11, 12, 13, and 
14) showed measurable radical scavenging 
activity with IC50s ranging from 33 to 100 µg/mL. 
Compounds 1, 4, 6, 7, 8, 9, 10, 11, 12, 13 and 14 
showed radical scavenging activity. Compound 
1, 4 and 7 each had lower IC50 values than the 
positive control. These findings suggest that 
Phyllostachys prominens leaves have potential 
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